Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp

<< Previous

Bullboard Posts

Next >>

Post by subaru1ion Feb 20, 2024 9:09am

67 Views

Post# 35888521

No one asked: Why didn't Pidduck disclose the name of their

'large generic pharmaceutical partner' in Brazil? He mentioned in 2023 that was a possibility after ANVISA approval. But yet he sits quietly only telling us of the approval but not disclosing the name.

There's more to the story for his reasoning.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec